| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.681 | 7.067 | 4.298 | 4.661 | 3.391 | 3.983 | 2.656 | 2.264 | - |
| Total Income - EUR | - | 5.681 | 7.067 | 4.298 | 4.661 | 3.391 | 3.983 | 2.656 | 2.264 | - |
| Total Expenses - EUR | - | 103 | 174 | 241 | 354 | 511 | 297 | 3.579 | 1.784 | - |
| Gross Profit/Loss - EUR | - | 5.578 | 6.893 | 4.057 | 4.308 | 2.881 | 3.686 | -922 | 480 | - |
| Net Profit/Loss - EUR | - | 5.408 | 6.681 | 3.928 | 4.167 | 2.787 | 3.566 | -1.002 | 403 | - |
| Employees | - | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | - |
Check the financial reports for the company - Respir Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 96 | 62 | 24 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | - | 5.411 | 7.025 | 6.363 | 5.163 | 7.849 | 11.251 | 3.429 | 1.797 | - |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | - | 631 | 345 | 0 | 0 | 440 | 394 | 406 | 485 | - |
| Cash | - | 4.779 | 6.680 | 6.363 | 5.163 | 7.409 | 10.857 | 3.023 | 1.312 | - |
| Shareholders Funds | - | 5.452 | 7.050 | 6.324 | 5.116 | 7.806 | 11.199 | 4.036 | 1.582 | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | 54 | 37 | 63 | 47 | 43 | 52 | 31 | 215 | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Respir Plus Srl